bluebird bio, Inc. Profile Avatar - Palmy Investing

bluebird bio, Inc.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of tran…

Biotechnology
US, Cambridge [HQ]

Lobbying Analysis

bluebird bio, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of BLUE's Analysis
CIK: 1293971 CUSIP: 09609G100 ISIN: US09609G1004 LEI: - UEI: -
Secondary Listings
BLUE has no secondary listings inside our databases.